Annual report
4538.TEDINET S100YHSC
Period2025-04-01 → 2026-03-31
Filed2026-06-23
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 88
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.3bn | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥60.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥55.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥51.0bn | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥49.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.6bn | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | ¥4.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.3bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.8bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.9bn | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.2bn | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.0bn | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.4bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥5.0bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | ¥2.0bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.4bn | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥90.3bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥81.7bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥75.8bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥72.5bn | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥69.3bn | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥55.3bn | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥48.7bn | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥35.1bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥33.0bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥36.7bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥35.6bn | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥34.5bn | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.8bn | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.3bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥4.8bn | at 2026-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥6.3bn | at 2025-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2024-03-31v | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥8.0bn | at 2023-03-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥7.3bn | at 2022-03-31v | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥6.2bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥627m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.9bn | 2022-04-01 → 2023-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.5bn | 2021-04-01 → 2022-03-31v | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.2bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥3.5bn | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.6bn | 2021-04-01 → 2022-03-31v | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥6.3bn | 2025-04-01 → 2026-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥7.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥14m | 2023-04-01 → 2024-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥813m | 2022-04-01 → 2023-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.7bn | 2021-04-01 → 2022-03-31v | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥235.63 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-384.95 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥159.98 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥183.07 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥169.09 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥90 | 2025-04-01 → 2026-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥82 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2023-04-01 → 2024-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥70 | 2022-04-01 → 2023-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31v | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,106.51 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,869.1 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,290.55 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥4,064.76 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,936.7 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 38.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.4% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.4% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.2% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.8% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 5.9% | 2025-04-01 → 2026-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -9.4% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2023-04-01 → 2024-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.6% | 2022-04-01 → 2023-03-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2021-04-01 → 2022-03-31v | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 9,451,169 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 9,451,169 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 1,374 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 1,340 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 1,307 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 1,314 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 1,344 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 2
| Segment | Item | Period | Value |
|---|---|---|---|
| Pharmaceutical Businessreportable segment | employees | at 2026-03-31 | 1268 pure |
| Real Estate Businessreportable segment | employees | at 2026-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,103
| Item | Context | Value | Unit |
|---|---|---|---|
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration_NonConsolidatedMember | -1549000000 | JPY |
| Other net ope cf | Prior1YearDuration_NonConsolidatedMember | 1649000000 | JPY |
| Other net ope cf | CurrentYearDuration_NonConsolidatedMember | 2022000000 | JPY |
| Subtotal ope cf | Prior1YearDuration_NonConsolidatedMember | -2893000000 | JPY |
| Subtotal ope cf | CurrentYearDuration_NonConsolidatedMember | -4685000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YearDuration_NonConsolidatedMember | 107000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYearDuration_NonConsolidatedMember | 142000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YearDuration_NonConsolidatedMember | -143000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYearDuration_NonConsolidatedMember | -338000000 | JPY |
| Income taxes paid ope cf | Prior1YearDuration_NonConsolidatedMember | -374000000 | JPY |
| Income taxes paid ope cf | CurrentYearDuration_NonConsolidatedMember | -1342000000 | JPY |
| Net cash provided by used in operating activities | Prior1YearDuration_NonConsolidatedMember | -3305000000 | JPY |
| Net cash provided by used in operating activities | CurrentYearDuration_NonConsolidatedMember | -6224000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YearDuration_NonConsolidatedMember | -2122000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYearDuration_NonConsolidatedMember | -1266000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YearDuration_NonConsolidatedMember | -976000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYearDuration_NonConsolidatedMember | -393000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYearDuration_NonConsolidatedMember | 261000000 | JPY |
| Other net inv cf | Prior1YearDuration_NonConsolidatedMember | -70000000 | JPY |
| Other net inv cf | CurrentYearDuration_NonConsolidatedMember | -116000000 | JPY |
| Net cash provided by used in investment activities | Prior1YearDuration_NonConsolidatedMember | -3168000000 | JPY |
| Net cash provided by used in investment activities | CurrentYearDuration_NonConsolidatedMember | -1515000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YearDuration_NonConsolidatedMember | 15650000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYearDuration_NonConsolidatedMember | 8000000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YearDuration_NonConsolidatedMember | 1300000000 | JPY |
| Proceeds from long term loans payable fin cf | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Repayment of long term loans payable fin cf | Prior1YearDuration_NonConsolidatedMember | -8382000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYearDuration_NonConsolidatedMember | -827000000 | JPY |
| Commision fee paid fin cf | Prior1YearDuration_NonConsolidatedMember | -303000000 | JPY |
| Commision fee paid fin cf | CurrentYearDuration_NonConsolidatedMember | -110000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YearDuration_NonConsolidatedMember | -4000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYearDuration_NonConsolidatedMember | -2000000 | JPY |
| Cash dividends paid fin cf | Prior1YearDuration_NonConsolidatedMember | -638000000 | JPY |
| Cash dividends paid fin cf | CurrentYearDuration_NonConsolidatedMember | -734000000 | JPY |
| Other net fin cf | Prior1YearDuration_NonConsolidatedMember | -3000000 | JPY |
| Other net fin cf | CurrentYearDuration_NonConsolidatedMember | -3000000 | JPY |
| Net cash provided by used in financing activities | Prior1YearDuration_NonConsolidatedMember | 7618000000 | JPY |
| Net cash provided by used in financing activities | CurrentYearDuration_NonConsolidatedMember | 6321000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YearDuration_NonConsolidatedMember | 1144000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYearDuration_NonConsolidatedMember | -1418000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant_NonConsolidatedMember | 5120000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 6264000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant_NonConsolidatedMember | 6264000000 | JPY |
| Cash and cash equivalents | CurrentYearInstant_NonConsolidatedMember | 4846000000 | JPY |
| Contract liabilities | Prior1YearInstant_NonConsolidatedMember | 187000000 | JPY |
| Contract liabilities | CurrentYearInstant_NonConsolidatedMember | 227000000 | JPY |
| Medicine department cost of sales inventories | Prior1YearDuration_NonConsolidatedMember | 469000000 | JPY |
| Medicine department cost of sales inventories | CurrentYearDuration_NonConsolidatedMember | 415000000 | JPY |
| Packing and transportation expenses sga | Prior1YearDuration_NonConsolidatedMember | 2330000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |